Startup gives surgeons a real-time view of breast cancer during surgery
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
Implantable microparticles can deliver two cancer therapies at once
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.
Seven with MIT ties elected to National Academy of Medicine for 2024
Professors Matthew Vander Heiden and Fan Wang, along with five MIT alumni, are honored for their outstanding professional achievement and commitment to service.
A new framework to efficiently screen drugs
Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
Cancer biologists discover a new mechanism for an old drug
Study reveals the drug, 5-fluorouracil, acts differently in different types of cancer — a finding that could help researchers design better drug combinations.
A new way to reprogram immune cells and direct them toward anti-tumor immunity
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
Engineering proteins to treat cancer
PhD student Oscar Molina seeks new ways to assemble proteins into targeted cancer therapies, while also encouraging his fellow first-generation graduate students.
Study reveals the benefits and downside of fasting
Fasting helps intestinal stem cells regenerate and heal injuries but also leads to a higher risk of cancer in mice, MIT researchers report.
AI model identifies certain breast tumor stages likely to progress to invasive cancer
The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.
A new way to miniaturize cell production for cancer treatment
A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.
Leaning into the immune system’s complexity
By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases.
A new way to spot life-threatening infections in cancer patients
Leuko, founded by a research team at MIT, is giving doctors a noninvasive way to monitor cancer patients’ health during chemotherapy — no blood tests needed.
New technique reveals how gene transcription is coordinated in cells
By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.
“Rosetta Stone” of cell signaling could expedite precision cancer medicine
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
The beauty of biology
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.